Literature DB >> 1940971

Residual signs in severe Guillain-Barré syndrome: analysis of 57 patients.

A E de Jager1, J M Minderhoud.   

Abstract

The residual signs in a group of seriously paralyzed Guillain-Barré patients are reported (follow-up 2-24 years) and the social effects of the illness are discussed. Thirty-five percent of the patients had recovered completely at the time of the follow-up examination, 35% had minimal residual motor signs and 30% had a moderate or severe residual paresis. The most serious residua were found distally in the legs. Muscles innervated by nerves running along an entrapment site had the most severe deficits. Sensory signs were present in 49% of the patients. More than half of the patients considered themselves to be cured. The others were more or less handicapped by their sequelae. Of the adults, 60% resumed work, 25% found a less demanding job and 15% did not return to work. Statistically significant correlations were found between the degree of residual motor deficit and the severity of the weakness in the acute phase, the duration of the plateau phase or the duration of the artificial ventilation.

Entities:  

Mesh:

Year:  1991        PMID: 1940971     DOI: 10.1016/0022-510x(91)90304-p

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Impaired joint mobility in Guillain-Barré syndrome: a primary or a secondary phenomenon?

Authors:  I Soryal; E Sinclair; J Hornby; B Pentland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

2.  Connecting impairment, disability, and handicap in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

3.  Long term disability and social status change after Guillain-Barré syndrome.

Authors:  A Bersano; M Carpo; S Allaria; D Franciotta; A Citterio; E Nobile-Orazio
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

4.  Residual health status after Guillain-Barré syndrome.

Authors:  R A Bernsen; H M Jacobs; A E de Jager; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

Review 5.  The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.

Authors:  F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 6.  Autonomic dysfunction in the neurological intensive care unit.

Authors:  Max J Hilz; Mao Liu; Sankanika Roy; Ruihao Wang
Journal:  Clin Auton Res       Date:  2018-07-18       Impact factor: 4.435

7.  A prospective study of physiotherapist prescribed community based exercise in inflammatory peripheral neuropathy.

Authors:  R C Graham; R A C Hughes; C M White
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

8.  Long-term outcome of Guillain-Barré syndrome.

Authors:  S Koeppen; K Kraywinkel; T E Wessendorf; C E Ehrenfeld; M Schürks; H C Diener; C Weimar
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

9.  Videofluoroscopic evaluation of patients with Guillain-Barré syndrome.

Authors:  M Y Chen; P D Donofrio; M G Frederick; D J Ott; L A Pikna
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

10.  Modified Zipper Method, a Promising Treatment Option in Severe Pediatric Immune-Mediated Neurologic Disorders.

Authors:  Marc Nikolaus; Fabienne Kühne; Anna Tietze; Julia Thumfart; Caroline Kempf; Alexander Gratopp; Ellen Knierim; Petra Bittigau; Angela M Kaindl
Journal:  J Child Neurol       Date:  2022-04-18       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.